Bracken, MB, Shepard, MJ, Collins, WF, et al.
A randomized,controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med
Vandertop, WP, Notermans, NC, Algra, A. Methylprednisolone intraumatic spinal cord injuries: not proven to be beneficial to the patient at the present time. Ned Tijdschr Geneeskd
Coleman, WP, Benzel, D, Cahill, DW, et al.
A critical appraisal of thereporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord
Hurlbert, RJ. Methylprednisolone for acute spinal cord injury: aninappropriate standard of care. J Neurosurg
Hurlbert, RJ. The role of steroids in acute spinal cord injury. Anevidence-based analysis. Spine
Nesathurai, S. Steroids and spinal cord injury: revisiting theNASCIS 2 and NASCIS 3 trials. J Trauma
Rosner, MJ. Methylprednisolone for spinal cord injury. J Neurosurg
1992;77(2):324–325; discussion 325-327.
Short, DJ, El Masry, WS, Jones, PW. High-dose methylprednisolonein the management of acute spinal cord injury “ a systematic review from a clinical perspective. Spinal Cord
Short, D. Use of steroids for acute spinal cord injury must bereassessed. BMJ
Wilkinson, HA. Spinalcord injury. J Neurosurg
Guidelines for the management of acute cervical spine and spinalcord injuries. Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Neurosurgery
Cook, DJ, Guyatt, GH, Laupacis, A, Sackett, DL. Rules of evidenceand clinical recommendations on the use of antithrombotic agents. Chest
Guyatt, GH, Sackett, DL, Cook, DJ. User’s guides to the Medical Literature. JAMA
Woolf, SH, Battista, RN, Anderson, GM, Logan, AG, Wang, E. Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. JClin Epidemiol
Pointillart, V, Petitjean, ME, Wiart, L, et al.
Pharmacological therapyof spinal cord injury during the acute phase. Spinal Cord
Petitjean, ME, Pointillart, V, Dixmerias, F, et al.
Medical treatment ofspinal cord injury in the acute stage. Ann Fr Anesth Reanim
Kiwerski, JE. Application of dexamethasone in the treatment ofacute spinal cord injury. Injury
Gabler, C, Maier, R. Clinical experiences and results of high-dosagemethylprednisolone therapy in spinal cord trauma 1991 to 1993. Unfallchirurg
Epstein, N, Hood, DC, Ransohoff, J. Gastrointestinal bleeding inpatients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin. J Neurosurg
Prendergast, MR, Saxe, JM, Ledgerwood, AM, Lucas, CE, Lucas, WF. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma
1994;37(4):576–579; discussion 579-580.
Levy, ML, Gans, W, Wijesinghe, HS, et al.
Use of methylprednisoloneas an adjunct in the management of patients with penetrating spinal cord injury: outcome analysis. Neurosurgery
1996;39(6):1141–1148; discussion 1148-1149.
Heary, RF, Vaccaro, AR, Mesa, JJ, et al.
Steroids and gunshot woundsto the spine. Neurosurgery
1997;41(3):576–583; discussion 583¬584.
Bracken, MB. Pharmacological intervention for acute spinal cordinjury (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
Bracken, MB. Methylprednisolone and acute spinal cord injury. Anupdate of randomized evidence. Spine
Bracken, MB, Collins, WF, Freeman, DF, et al.
Efficacy ofmethylprednisolone in acute spinal cord injury. JAMA
Bracken, MB, Shepard, MJ, Hellenbrand, KG, et al.
Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg
Bracken, MB, Shepard, MJ, Collins, WF Jr, et al.
Methylprednisoloneor naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg
Bracken, MB, Shepard, MJ, Holford, TR, et al.
Administration ofmethylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA
Bracken, MB, Shepard, MJ, Holford, TR, et al. Methylprednisolone ortirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg
Matsumoto, T, Tamaki, T, Kawakami, M, et al.
Early complications ofhigh-dose methylprednisolone sodium succinate treatment in the follow-upofacute cervical spinal cord injury. Spine
Shepard, MJ, Bracken, MB. The effect of methylprednisolone,naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study. Paraplegia
Otani, K, Abe, H, Kadoya, S, et al.
Beneficialeffect ofmethylprednisolone sodium succinate in the treatment of acute spinal cord injury. Sekitsui Sekizui J
Poynton, AR, O’Farrell, DA, Shannon, F, et al.
An evaluation of thefactors affecting neurological recovery following spinal cordinjury. Injury
Wing, PC, Nance, P, Connell, DG, Gagnon, F. Risk of avascularnecrosis following short-term megadose methylprednisolone treatment. Spinal Cord
Gerhart, KA, Johnson, RL, Menconi, J, Hoffman, RE, Lammertse, DP. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia
Frankel, HL, Hancock, DO, Hyslop, G. The value of posturalreduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Part I. Paraplegia
George, ER, Scholten, DJ, Buechler, CM, et al.
Failure ofmethylprednisolone to improve the outcome of spinal cord injuries. Am Surg
1995;61(8):659–663; discussion 663-664.
Galandiuk, S, Raque, G, Appel, S, Polk, HC Jr. The two-edged swordof large-dose steroids for spinal cord trauma. Ann Surg
1993;218(4):419–425; discussion 425-427.
Gerndt, SJ, Rodriguez, JL, Pawlik, JW, et al.
Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma
Sauerland, S, Nagelschmidt, M, Mallmann, P, Neugebauer, EAM. Risks and benefits of preoperative high-dose methylprednisolone insurgicalpatients. A systematicreview. Drug Safety
Bedbrook, G. Recovery of spinal cord function. Paraplegia
Gerhart, KA. Spinal cord injury outcomes in a population-basedsample. J Trauma
Waters, RL, Adkins, RH, Yakura, JS, Sie, I. Motor and sensoryrecovery following complete tetraplegia. Arch Phys Med Rehabil
Burns, SP, Golding, DG, Rolle, WA Jr, Graziani, V, Ditunno, JF Jr. Recovery of ambulation in motor-incomplete tetraplegia. Arch Phys Med Rehabil
Marino, RJ, Ditunno, JF, Donovan, WH, Maynard, F Jr. Neurologicrecovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Sytems. Arch Phys Med Rehabil
Ditunno, JF Jr, Cohen, ME, Formal, C, Whiteneck, GG. Functionaloutcomes. In: Stover, SL, DeLisa, JA, Whiteneck, GG (Eds). Spinal Cord Injury. Clinical Outcomes from the Model Systems. Gaithersburg, Maryland: Aspen, 1995;170–184.
Ditunno, JF Jr, Stover, SL, Freed, MM, Ahn, JH. Motor recovery of theupper extremities in traumatic quadriplegia: a multicenter study. Arch Phys Med Rehabil
Ditunno, JF Jr. Predicting recovery after spinal cord injury: arehabilitation imperative. Arch Phys Med Rehabil
Frankel, HL, Hancock, DO, Hyslop, G. The value of postural reductionin the initial management of closed injuries of the spine with paraplegia and tetraplegia. Part I. Paraplegia
American Spinal Injury Association: Standards for NeurologicalClassification of Spinal Cord Patients. Chicago. American Spinal Injury Association
Outcomes following traumatic spinal cord injury: clinical practiceguidelines for health care professionals. Clinical Practice Guidelines, Spinal Cord Medicine 1999 July. Paralyzed Victims of America.
Young, W, Bracken, MB. The Second National Acute Spinal CordInjury Study. J Neurotrauma
Bracken, MB. Treatment of acutespinalcord injury withmethylprednisolone: results of a multicenter, randomized clinical trial. J Neurotrauma
1991;8(Suppl 1):S47-50; discussion S51-S52.
Bracken, MB. Pharmacological treatment of acute spinal cord injury:current status and future prospects. Paraplegia
Bracken, MB. Pharmacological treatment of acute spinal cord injury:current status and future projects. J Emerg Med
1993; 11 Suppl 1:43–48.
Bracken, MB, Holford, TR. Effects of timing of methylprednisoloneor naloxone administration on recovery of segmental and long-tractneurologicalfunction in NASCIS 2. J Neurosurg
Bracken, MB, Aldrich, EF, Herr, DL, et al.
Clinical measurement,statistical analysis, and risk-benefit: controversies from trials of spinal injury. J Trauma
Bracken, MB. Methylprednisolone and spinal cord injury. J Neurosurg